COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 157 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $438,798 | +17.4% | 19,633 | +12.9% | 0.00% | – |
Q2 2023 | $373,625 | -37.9% | 17,386 | -30.7% | 0.00% | – |
Q1 2023 | $601,669 | +58.7% | 25,080 | +53.4% | 0.00% | – |
Q4 2022 | $379,204 | +47.6% | 16,345 | +1.8% | 0.00% | – |
Q3 2022 | $257,000 | -20.7% | 16,050 | -12.2% | 0.00% | – |
Q2 2022 | $324,000 | -23.0% | 18,278 | -11.6% | 0.00% | – |
Q1 2022 | $421,000 | -0.9% | 20,668 | -9.1% | 0.00% | – |
Q4 2021 | $425,000 | -4.1% | 22,737 | +1.4% | 0.00% | – |
Q3 2021 | $443,000 | -92.1% | 22,428 | -90.6% | 0.00% | -100.0% |
Q2 2021 | $5,632,000 | +215.9% | 238,252 | +216.7% | 0.00% | +200.0% |
Q1 2021 | $1,783,000 | +245.5% | 75,238 | +192.0% | 0.00% | – |
Q4 2020 | $516,000 | -27.1% | 25,764 | -24.4% | 0.00% | – |
Q3 2020 | $708,000 | -46.6% | 34,059 | -55.0% | 0.00% | -100.0% |
Q2 2020 | $1,325,000 | +201.1% | 75,659 | +180.8% | 0.00% | – |
Q1 2020 | $440,000 | -83.8% | 26,944 | -79.7% | 0.00% | -100.0% |
Q4 2019 | $2,723,000 | +44.8% | 132,424 | -19.3% | 0.00% | +100.0% |
Q3 2019 | $1,881,000 | -25.4% | 164,003 | -14.5% | 0.00% | 0.0% |
Q2 2019 | $2,521,000 | +384.8% | 191,837 | +455.8% | 0.00% | – |
Q1 2019 | $520,000 | -28.3% | 34,514 | -18.4% | 0.00% | -100.0% |
Q4 2018 | $725,000 | -65.4% | 42,278 | -70.3% | 0.00% | 0.0% |
Q3 2018 | $2,098,000 | -74.8% | 142,399 | -59.2% | 0.00% | -50.0% |
Q2 2018 | $8,331,000 | -3.0% | 349,415 | +3.9% | 0.00% | -50.0% |
Q1 2018 | $8,592,000 | +12.4% | 336,357 | -18.8% | 0.00% | -20.0% |
Q4 2017 | $7,643,000 | +1009.3% | 414,115 | +528.0% | 0.01% | – |
Q3 2017 | $689,000 | -14.0% | 65,946 | +2.8% | 0.00% | -100.0% |
Q2 2017 | $801,000 | +150.3% | 64,121 | +100.1% | 0.00% | – |
Q1 2017 | $320,000 | -80.5% | 32,038 | -69.7% | 0.00% | -100.0% |
Q4 2016 | $1,643,000 | -30.9% | 105,662 | -14.5% | 0.00% | -50.0% |
Q3 2016 | $2,379,000 | +197.0% | 123,628 | +82.6% | 0.00% | +100.0% |
Q2 2016 | $801,000 | +725.8% | 67,697 | +1148.1% | 0.00% | – |
Q1 2016 | $97,000 | -16.4% | 5,424 | +26.6% | 0.00% | – |
Q4 2015 | $116,000 | -74.0% | 4,285 | -78.9% | 0.00% | – |
Q3 2015 | $447,000 | +1496.4% | 20,269 | +1164.4% | 0.00% | – |
Q2 2015 | $28,000 | – | 1,603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |